Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component
Authors:
- 6 October 2012
- journal article
- Published by Springer Nature in Glycoconjugate Journal
- Vol. 30 (5) , 511-522
Abstract
State-of-the-art production technologies for conjugate vaccines are complex, multi-step processes. An alternative approach to produce glycoconjugates is based on the bacterial N-linked protein glycosylation system first described in Campylobacter jejuni. The C. jejuni N-glycosylation system has been successfully transferred into Escherichia coli, enabling in vivo production of customized recombinant glycoproteins. However, some antigenic bacterial cell surface polysaccharides, like the Vi antigen of Salmonella enterica serovar Typhi, have not been reported to be accessible to the bacterial oligosaccharyltransferase PglB, hence hamper development of novel conjugate vaccines against typhoid fever. In this report, Vi-like polysaccharide structures that can be transferred by PglB were evaluated as typhoid vaccine components. A polysaccharide fulfilling these requirements was found in Escherichia coli serovar O121. Inactivation of the E. coli O121 O antigen cluster encoded gene wbqG resulted in expression of O polysaccharides reactive with antibodies raised against the Vi antigen. The structure of the recombinantly expressed mutant O polysaccharide was elucidated using a novel HPLC and mass spectrometry based method for purified undecaprenyl pyrophosphate (Und-PP) linked glycans, and the presence of epitopes also found in the Vi antigen was confirmed. The mutant O antigen structure was transferred to acceptor proteins using the bacterial N-glycosylation system, and immunogenicity of the resulting conjugates was evaluated in mice. The conjugate-induced antibodies reacted in an enzyme-linked immunosorbent assay with E. coli O121 LPS. One animal developed a significant rise in serum immunoglobulin anti-Vi titer upon immunization.Keywords
This publication has 40 references indexed in Scilit:
- Production of glycoprotein vaccines in Escherichia coliMicrobial Cell Factories, 2010
- Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine componentProceedings of the National Academy of Sciences, 2008
- Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systemsProceedings of the National Academy of Sciences, 2006
- Definition of the bacterial N‐glycosylation site consensus sequenceThe EMBO Journal, 2006
- Chemical Structure, Conjugation, and Cross-Reactivity ofBacillus pumilusSh18 Cell Wall PolysaccharideJournal of Bacteriology, 2004
- The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old ChildrenNew England Journal of Medicine, 2001
- The Activity of a Putative Polyisoprenol-linked Sugar Translocase (Wzx) Involved in Escherichia coli O Antigen Assembly Is Independent of the Chemical Structure of the O RepeatJournal of Biological Chemistry, 1999
- A set of compatible tac promoter expression vectorsGene, 1996
- Construction of a broad host range cosmid cloning vector and its use in the genetic analysis of Rhizobium mutantsGene, 1982
- Maturation of the head of bacteriophage T4Journal of Molecular Biology, 1973